Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
This study has been completed.
Ian F. Pollack, M.D.
First Posted: November 21, 2008
Last Update Posted: July 6, 2017
Information provided by (Responsible Party):
Ian F. Pollack, M.D., University of Pittsburgh
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2015|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|